Zacks Research Has Negative Forecast for BAX Q3 Earnings

Baxter International Inc. (NYSE:BAX) – Stock analysts at Zacks Research decreased their Q3 2028 earnings estimates for shares of Baxter International in a research report issued to clients and investors on Monday, September 28th. Zacks Research analyst Team now forecasts that the medical instruments supplier will post earnings of $0.54 per share for the quarter, down from their prior estimate of $0.55. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Baxter International’s current full-year earnings is $2.04 per share.

Several other equities analysts have also recently weighed in on the stock. The Goldman Sachs Group increased their price objective on shares of Baxter International from $19.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 15th. TD Cowen upped their target price on shares of Baxter International from $20.00 to $24.00 and gave the company a “hold” rating in a report on Monday, July 27th. UBS Group lifted their price target on shares of Baxter International from $19.00 to $25.00 and gave the stock a “hold” rating in a research note on Tuesday, July 28th. Wells Fargo & Company boosted their price objective on shares of Baxter International from $19.00 to $23.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Finally, Weiss Ratings raised Baxter International from a “sell (d-)” rating to a “sell (d)” rating in a report on Friday, July 31st. Two analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Baxter International currently has an average rating of “Hold” and a consensus price target of $22.45.

Baxter International Stock Down 1.6%

BAX stock opened at $23.62 on Friday. The company has a market cap of $12.21 billion, a price-to-earnings ratio of -11.41, a P/E/G ratio of 3.63 and a beta of 0.66. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.32 and a current ratio of 1.95. The business’s 50-day moving average is $25.30 and its two-hundred day moving average is $21.29. Baxter International has a fifty-two week low of $15.73 and a fifty-two week high of $30.00.

Baxter International (NYSE:BAX) last released its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.19. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%.The firm had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $2.80 billion. During the same period in the prior year, the firm earned $0.59 EPS. The company’s revenue was up 5.3% compared to the same quarter last year. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS.

Baxter International Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, October 1st. Investors of record on Friday, August 28th were issued a $0.01 dividend. The ex-dividend date of this dividend was Friday, August 28th. This represents a $0.04 annualized dividend and a yield of 0.2%. Baxter International’s dividend payout ratio is currently -1.93%.

Institutional Investors Weigh In On Baxter International

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Jones Financial Companies Lllp purchased a new stake in shares of Baxter International during the second quarter worth about $26,000. CYBER HORNET ETFs LLC lifted its holdings in Baxter International by 52.4% in the 2nd quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier’s stock worth $46,000 after purchasing an additional 740 shares in the last quarter. Community Bank N.A. bought a new position in Baxter International in the 2nd quarter worth approximately $46,000. Versant Capital Management Inc grew its holdings in Baxter International by 552.2% during the 2nd quarter. Versant Capital Management Inc now owns 2,413 shares of the medical instruments supplier’s stock valued at $51,000 after buying an additional 2,043 shares in the last quarter. Finally, EFG International AG bought a new stake in shares of Baxter International during the second quarter valued at approximately $67,000. 90.19% of the stock is owned by institutional investors.

More Baxter International News

Here are the key news stories impacting Baxter International this week:

• Positive Sentiment: Baxter released its inaugural Connected Hospital Report, highlighting the potential for connected medical technologies to improve hospital efficiency, patient care and clinical decision-making. The report may strengthen Baxter’s strategic positioning in digital and connected healthcare, although it does not provide a material near-term financial update. Baxter Releases Inaugural Connected Hospital Report

Baxter International Company Profile

Baxter International Inc is a global healthcare company that develops and markets products used in hospitals, outpatient facilities and other care settings. Its portfolio includes intravenous solutions and administration sets, infusion pumps, parenteral nutrition products, injectable medicines, surgical products and systems for medication preparation and delivery.

The company also provides products and technologies that support anesthesia, critical care, patient monitoring and other hospital workflows.